| Literature DB >> 35005219 |
Jenni Hämäläinen1, Tarja Kvist1, Päivi Kankkunen1.
Abstract
For many patients, acute pain is a common cause to seek treatment in an Emergency Department (ED). An inadequate assessment could cause inappropriate pain management. The aim of this study was to describe and explain patients' perceptions of acute pain assessment in the Emergency Department. The data were collected from ED patients (n = 114). Patients reported that nurses were asking about intensity of pain at rest, but only 52% during movement. According to the patients, the most common tools to assess acute pain were the verbal rating scale (VRS; 54% of patients), numerical rating scale (NRS; 28% of patients), and visual analogue scale (VAS; 9.7% of patients). Over twenty per cent of patients stated that ED nurses did not ask about the intensity of pain after analgesic administration. Twenty-four per cent of the patients were not pleased with nursing pain assessment in the ED. The assessment of acute pain is still inadequate in the ED. Therefore, ED nurses need to be more attentive to systematic acute pain management of patients in the ED.Entities:
Keywords: acute pain; emergency department; pain assessment; pain management; patient
Year: 2022 PMID: 35005219 PMCID: PMC8733361 DOI: 10.1177/23743735211049677
Source DB: PubMed Journal: J Patient Exp ISSN: 2374-3735
Sociodemographic Characteristics of Nurses (n = 114, n, %).
| Characteristics | n | % | |
|---|---|---|---|
| Age (years) | Under 24 | 19 | 17 |
| 25–39 | 38 | 33 | |
| 40–58 | 41 | 36 | |
| 60 and older | 16 | 14 | |
| Gender | Female | 67 | 58.8 |
| Male | 47 | 41.2 | |
| Married | 53 | 46.5 | |
| Cohabitation | 33 | 28.9 | |
| Unmarried | 15 | 13.2 | |
| Divorced | 10 | 8.8 | |
| Widow | 3 | 2.6 | |
| Educational level (degree) | Master's | 39 | 34.2 |
| Vocational | 34 | 29.8 | |
| Comprehensive School | 18 | 15.8 | |
| College | 14 | 12.3 | |
| Bachelor's | 9 | 7.9 | |
| Working life situation | Employee | 60 | 52.6 |
| Lower Officer | 13 | 11.4 | |
| Pensioner | 12 | 10.5 | |
| Student | 10 | 8.8 | |
| Senior Officer | 8 | 7.0 | |
| Unemployed | 6 | 5.3 | |
| Enterpreneur | 5 | 4.4 | |
| Long-term painful illnesses | No | 110 | 96.5 |
| Yes | 0 | 0 | |
| Missing Value | 4 | 3.5 | |
| Acute pain in current time (NRS 0–10), (mean 5,46) (n = 111) | 4–7 | 80 | 70.2 |
| 0–3 | 17 | 14.9 | |
| 8–10 | 14 | 12.3 | |
| Missing Value | 3 | 2.6 |
Patiens’ Perceptions of Pain Frequency, Pain Scales, Pain Quality, and Pain Intensity (n = 114, n, %).
| Items: | Strongly agree (n, %) | Partially agree (n, %) | Do not know, (n, %) | Partially disagree (n, %) | Strongly disagree (n, %) | Missing |
|---|---|---|---|---|---|---|
| Nurses’ asked the location of my pain | 82 (71.9%) | 20 (17.5%) | 0 (0%) | 10 (8.8%) | 1 (0.9%) | 1 (0.9%) |
| Nurses’ asked type of my pain | 55 (48.2%) | 36 (31.6%) | 6 (5.3%) | 15 (13.2%) | 1 (0.9%) | 1 (0.9%) |
| Nurses’ asked my acute pain at entry | 69 (60.5%) | 26 (22.8%) | 3 (2.6%) | 15 (13.2%) | 1 (0.9%) | 0 (0%) |
| Nurses’ asked my acute pain at departure | 40 (35.1%) | 32 (28.1%) | 0 (0%) | 17 (14.9%) | 3 (2.6%) | 22 (19.3%) |
| My pain was assessed several times while I was in the Emergency Department | 57 (50.0%) | 32 (28.1%) | 0 (0%) | 20 (1750%) | 4 (3.6%) | 2 (0.8%) |
| Assessing the intensity of pain is challenging | 47 (41.2%) | 57 (50.0%) | 2 (1.8%) | 8 (7.0%) | 0 (0%) | 0 (0%) |
| Nurses’ assessed my pain with pain scale. | 57 (50%) | 23 (20.2%) | 2 (1.8%) | 6 (5.3%) | 6 (5.3%) | 20 (17.5%) |
| Pain assessment when the VAS
| 6 (5.3%) | 5 (4.4%) | 10 (8.8%) | 2 (1.8%) | 0 (0%) | 91 (79.8%) |
| Pain assessment when the VRS was used | 24 (21.1%) | 38 (33.3%) | 6 (5.3%) | 0 (0%) | 0 (0%) | 46 (40.4%) |
| Pain assessment when the NRS
| 17 (14.9%) | 15 (13.2%) | 0 (0%) | 0 (0%) | 0 (0%) | 82 (71.9%) |
| My self-assessment of pain intensity is the most reliable | 38 (33.3%) | 52 (45.6%) | 8 (7.0%) | 12 (10.5%) | 4 (3.5%) | 0 (0%) |
| My self-assessment of pain is as valid as the assessment made by a nurse or doctor | 29 (25.4%) | 50 (43.9%) | 5 (4.4%) | 22 (19.3%) | 5 (4.4%) | 3 (2.6%) |
| I am pleased to with nurses’ pain assessment | 44 (38.6%) | 44 (38.6%) | 2 (1.8%) | 17 (14.9%) | 6 (5.3%) | 1 (0.9%) |
| ED staff assessment adequately managed my pain | 57 (50.0%) | 33 (28.9%) | 17 (14.9%) | 5 (4.4%) | 1 (0.9%) | 1 (0.9%) |
| Nurses’ asked my pain at rest | 47 (41.2%) | 40 (35.1%) | 1 (0.9%) | 20 (17.5%) | 5 (4.4%) | 1 (0.9%) |
| Nurses’ asked my pain during motion | 30 (26.3%) | 29 (25.4%) | 6 (5.3%) | 35 (30.7%) | 13 (11.4%) | 1 (0.9%) |
| Nurses’ asked my pain before analgesics | 47 (41.2%) | 26 (22.8%) | 6 (5.3%) | 24 (21.1%) | 7 (6.1%) | 4 (3.5%) |
| Nurses’ asked my pain after analgesics | 54 (47.4%) | 22 (19.3%) | 11 (9.6%) | 18 (15.8%) | 7 (6.1%) | 2 (1.8%) |
Range. 1 = fully agree 5 = fully disagree.
Abbreviations: ED, Emergency Department; VAS, visual analogue scale; VRS, verbal rating scale: NRS; numerical rating scale;.
VAS scale: https://greatbrook.com/visual-analog-survey-scale/.
NRS scale: https://www.physio-pedia.com/Numeric_Pain_Rating_Scale.
Results of Exploratory Factor Analyses of Acute Pain Assessment (n = 114) (Loadings, Eigenvalues, Cronbach's Alpha Values).
| Factor Items | Loading | Eigen values | Cronbach`s alpha values |
|---|---|---|---|
| (1) Quality and frequency of the assessment of the acute pain | 4.828 | 0.85 | |
| Nurses’ asked the location of my pain | 0.86 | ||
| Nurses’ asked type of my pain | 0.73 | ||
| Nurses’ asked my acute pain at entry | 0.79 | ||
| Nurses’ asked my acute pain at departure | 0.73 | ||
| My pain was assessed several times while I was in the Emergency Department | 0.50 | ||
| (2) Patients’ self-assessment of pain | 1.43 | 0.75 | |
| My self-assessment of pain intensity is the most reliable | 0.63 | ||
| My self-assessment of pain is as valid as the assessment made by a nurse or doctor | 0.69 | ||
| I am pleased to with nurses’ pain assessment ED staff assessment adequately managed my pain | 0.74 | ||
| (3) Assessment of acute pain intensity at rest, and during movement, and intensity before and after administration of analgesics | 1.23 | 0.67 | |
| Nurses’ asked my pain at rest | 0.84 | ||
| Nurses’ asked my pain during motion | 0.62 | ||
| Nurses’ asked my pain before analgesic | 0.71 |
Relationships Between Background Variables and Pain Variables.
| Quality and frequency of the assessment of the acute pain | Patients’ self-assessment of pain | Assessment of acute pain intensity at rest, and during movement, and intensity before and after administration of analgesics | |
|---|---|---|---|
| Age1 (years) | 0.701 | 0.902 | 0.400 |
| Gender3 | 0.210 | 0.170 | |
| Marital Status1 | 0.375 | 0.412 | 0.604 |
| Educational level1 | 0.366 | 0.108 | 0.832 |
| Situation in working life1 | 0.066 | 0.109 | 0.132 |
Note: *p-value < 0.1, **p-value < 0.05 considered significant and bolded.
1 H = Kruskal-Wallis test value, 2 Mean, 3 U = Mann- Whitney U -test value
STROBE Statement—checklist of items that should be included in reports of observational studies
| Item No | Recommendation | Page | |
|---|---|---|---|
|
| 1 | ( | 1 |
| ( | 1–2 | ||
|
| |||
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported | 2–3 |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses | 3 |
|
| |||
| Study design | 4 | Present key elements of study design early in the paper | 3–5 |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection | 3–5 |
| Participants | 6 | ( | 3–4 |
| ( | |||
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable | 3–6 |
| Data sources/ measurement | 8
| For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group | 3–6 |
| Bias | 9 | Describe any efforts to address potential sources of bias | 10 |
| Study size | 10 | Explain how the study size was arrived at | 3–5 |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why | 4–7 |
| Statistical methods | 12 | ( | 4–5 |
| ( | |||
| ( | |||
| ( | |||
| ( | |||
|
| |||
| Participants | 13
| (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed | 5–6 |
| (b) Give reasons for non-participation at each stage | |||
| (c) Consider use of a flow diagram | |||
| Descriptive data | 14
| (a) Give characteristics of study participants (eg demographic, clinical, social) and information on exposures and potential confounders | 5–6 |
| (b) Indicate number of participants with missing data for each variable of interest | |||
| (c) | |||
| Outcome data | 15
| ||
| 6–10 | |||
| Main results | 16 | ( | 6–10 |
| ( | |||
| ( | |||
| Other analyses | 17 | Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses | |
|
| |||
| Key results | 18 | Summarise key results with reference to study objectives | 8–10 |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias | 10 |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence | 8–10 |
| Generalisability | 21 | Discuss the generalisability (external validity) of the study results | 8–10 |
|
| |||
| Funding | 22 | Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based | not applicable |
Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org